US Patent Issued to Memorial Sloan Kettering Cancer Center on June 2 for "Anti-CD20 antibody and uses thereof" (New York Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,953, issued on June 2, was assigned to Memorial Sloan Kettering Cancer Center (New York).

"Anti-CD20 antibody and uses thereof" was invented by Isabelle Riviere (New York), Ouathek Ouerfelli (New York), Xiuyan Wang (New York) and Frances Weis-Garcia (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are anti-CD20 antibodies and uses thereof for treatment and diagnosis. Also provided are CD20 antigens for the production of anti-CD20 antibodies and methods of generating anti-CD20 antibodies using the CD20 antigens."

The patent was filed on June 8, 2023, under Application No. 18/331,862.

*For further information, including images...